Vector BioMed (VBM), a leading lentiviral vector CDMO advancing access to gene therapies, will showcase its innovations at two major industry events this May: the International Society for Cell & Gene ...

ViroCell manufactured a GMP lentiviral vector for UCL to accelerate research into prevention of relapse in childhood blood cancer UCL leveraged ViroCell’s expertise in lentiviral vector manufacturing ...

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...

Genetically modified CAR T-cells targeting CD19 have shown impressive ... focused on leveraging our experience in viral vector design and manufacture to efficiently bring innovative therapies ...

Viral Vector Manufacturing Facility Pty Ltd (VVMF) has selected SYSPRO for its Cloud ERP system. VVMF is Australia’s first ...

Base-editing technologies along with AAV engineering not only help reduce costs but can also accelerate preclinical therapeutic development.

Tesela Copilot Accelerates R&D, Fully Embedded in TeselaGen's Cutting-Edge ELN and Platform PORTOLA VALLEY, CALIFORNIA / ACCESS Newswire / May 5, 2025 / TeselaGen, a leading provider of AI-augmented d ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...